BioSpace· Gabrielle Masson·· 3 hours agoPickScore83
Roche returns to Hansoh with broad $15B ADC deal
In brief
Roche has signed a licensing agreement with several subsidiaries of Hansoh Pharmaceutical covering a broad portfolio of ADCs. The deal totals up to $15 billion, including $400 million upfront, $110 million payable at the one-year mark, and the remainder through milestones and tiered sales royalties.
Why it matters
The source gives the upfront payment, one-year payment and cap, letting readers compare with the two companies' ADC licensing deal a year ago.
Source: BioSpace